Stephens & Co. Maintains Overweight on JBS, Lowers Price Target to $17

Benzinga Newsdesk www.benzinga.com Negative 81.3%

Neg 81.3% Neu 0% Pos 0%

Stephens & Co. analyst Pooran Sharma maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $18 to $17.